Sarah Clarke

Dec 10, 2024 | mondaq.com | Cheese Consumers |Sarah Clarke

As regular Big Molecule Watch readers know, the Biologics Price Competition and Innovation Act ("BPCIA") was signed into law as part of the Affordable Care Act on March 23, 2010, creating an abbreviated licensure pathway for "biosimilar" and "interchangeable" biological products.

Dec 4, 2024 | scirp.org | Sarah Clarke |Michele Marie Gandolfi

1. IntroductionCholesteatoma, or more specifically acquired cholesteatoma, is a well-known cystic lesion of the ear caused by either perforation or eustachian tube dysfunction that seeds epithelium into the middle ear and mastoid [1]. Bony erosion is usually confined to the ossicular chain and scutum at least initially but over time can cause erosion of the otic capsule, fallopian canal and tegmen. Tegmen erosion often leads to cephalocele or cerebral spinal fluid (CSF) leak.

Mar 28, 2024 | lexology.com | Sarah Clarke

Vaultex v Bialas EA-2022- 001258-ATSummary1. In an appeal in which I acted for the successful Appellant, HHJ Auerbach set aside a finding of unfair dismissal on the basis that the tribunal judge had substituted his own view and erred in law in respect of the range of reasonable responses test. The Facts2. Vaultex UK Ltd is the UK’s leading cash management company.

Mar 4, 2024 | lexology.com | Sarah Clarke

Jones v The Secretary of State for Health and Social Care EA-2022-000744-JOJSummary1. In a judgment handed down by HHJ Tayler, a perversity appeal on the ‘just and equitable’ extension of time was dismissed, and a useful commentary on the correct test to be applied was provided. The Facts2. The claimant applied for the role of Assistant Business development Manager in March 2019. He was successful in a paper sift and he attended an interview on 28 March 2019.

Sep 7, 2023 | lexology.com | Sarah Clarke

Rajput v Commerzbank and Société Générale [2023] EATSummary1. In a judgment handed down by Mr Justice Kerr this week in a case in which I represented the Appellant, the EAT found that in a ‘series of transactions’ case under Regulation 3(6) TUPE, the transfer did not necessarily take place at the end of the series, and that the tribunal should not focus merely on transactions which occurred within the UK. The Facts2.